Stoke Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
39.36
|
|
Average Rating
|
4.36
|
|
# Strong Buys
|
6
|
|
# Buys
|
4
|
|
# Holds
|
0
|
|
# Sells
|
1
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.68
|
-0.66
|
0.02
|
2.94%
|
|
2022-06-30
|
-0.69
|
-0.63
|
0.06
|
8.70%
|
|
2022-03-31
|
0.36
|
-0.66
|
-1.02
|
-283.33%
|
|
2021-12-31
|
-0.62
|
-0.66
|
-0.04
|
-6.45%
|
|
2021-09-30
|
-0.59
|
-0.61
|
-0.02
|
-3.39%
|
|
2021-06-30
|
-0.47
|
-0.60
|
-0.13
|
-27.66%
|
|
2021-03-31
|
-0.44
|
-0.46
|
-0.02
|
-4.55%
|
|
2020-12-31
|
-0.42
|
-0.42
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.95
|
|
2021-12-31
|
-2.33
|
|
2020-12-31
|
-1.56
|
|
2019-12-31
|
-8.78
|